Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | CNR2 | P34972 | 4/20 | 0.31 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.31 |
| ▸ | FEN1 | P39748 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | CNR1 | P21554 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21114734 | 0.84 | POLB (0.36) | LMNAPOLBALDH1A1CNR2HTT | |
| SCHEMBL375726 | 0.84 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL12079740 | 0.75 | LMNA (0.39) | LMNAPOLBALDH1A1HTTRXFP1 | |
| SCHEMBL18279842 | 0.74 | LMNA (0.39) | LMNAPOLBALDH1A1CNR2CYP1A2 | |
| SCHEMBL329862 | 0.72 | ALDH1A1 (0.38) | ALDH1A1 | |
| SCHEMBL12079221 | 0.71 | POLB (0.36) | LMNAPOLBALDH1A1CNR2CYP1A2 | |
| SCHEMBL11567681 | 0.71 | LMNA (0.41) | LMNAPOLBALDH1A1HTTRXFP1 | |
| Water SCHEMBL17042493 | 0.69 | LMNA (0.40) | LMNAPOLBALDH1A1HTTRXFP1 | |
| SCHEMBL12090683 | 0.68 | POLB (0.39) | LMNAPOLBALDH1A1CNR2CYP1A2 | |
| SCHEMBL18544153 | 0.68 | EPHX1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2976408-A1 | METHODS FOR CONSOLIDATION TREATMENTS IN SUBTERRANEAN FORMATIONS USING SILICON COMPOUNDS DERIVED FROM FURFURYL ALCOHOLS | Halliburton Energy Services, Inc. (US) | 2016-01-27 | — | — | EP | claimed |
| US-20140284054-A1 | Methods for Consolidation Treatments in Subterranean Formations Using Silicon Compounds Derived from Furfuryl Alcohols | HALLIBURTON ENERGY SERVICES, INC. (US) | 2014-09-25 | — | — | US | claimed |
| WO-2014151371-A1 | METHODS FOR CONSOLIDATION TREATMENTS IN SUBTERRANEAN FORMATIONS USING SILICON COMPOUNDS DERIVED FROM FURFURYL ALCOHOLS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2014-09-25 | — | — | WO | claimed |
| US-8779080-B2 | Silicon compounds derived from furfuryl alcohols and methods of preparation | GELEST TECHNOLOGIES, INC. (US) | 2014-07-15 | — | — | US | claimed |
| US-20140046017-A1 | SILICON COMPOUNDS DERIVED FROM FURFURYL ALCOHOLS AND METHODS OF PREPARATION | GELEST TECHNOLOGIES, INC. (US) | 2014-02-13 | — | — | US | claimed |
| US-20120226002-A1 | SILICON COMPOUNDS DERIVED FROM FURFURYL ALCOHOLS AND METHODS OF PREPARATION | GELEST TECHNOLOGIES, INC. (US) | 2012-09-06 | — | — | US | claimed |
| US-9969926-B2 | Methods for consolidation treatments in subterranean formations using silicon compounds derived from furfuryl alcohols | HALLIBURTON ENERGY SERVICES, INC. (US) | 2018-05-15 | — | — | US | disclosed |
| US-20170015892-A1 | Methods for Consolidation Treatments in Subterranean Formations Using Silicon Compounds Derived from Furfuryl Alcohols | HALLIBURTON ENERGY SERVICES, INC. | 2017-01-19 | — | — | US | disclosed |
| US-9487692-B2 | Methods for consolidation treatments in subterranean formations using silicon compounds derived from furfuryl alcohols | HALLIBURTON ENERGY SERVICES, INC. (US) | 2016-11-08 | — | — | US | disclosed |
| EP-2976408-A1 | METHODS FOR CONSOLIDATION TREATMENTS IN SUBTERRANEAN FORMATIONS USING SILICON COMPOUNDS DERIVED FROM FURFURYL ALCOHOLS | Halliburton Energy Services, Inc. (US) | 2016-01-27 | — | — | EP | disclosed |
| WO-2014151371-A1 | METHODS FOR CONSOLIDATION TREATMENTS IN SUBTERRANEAN FORMATIONS USING SILICON COMPOUNDS DERIVED FROM FURFURYL ALCOHOLS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2014-09-25 | — | — | WO | disclosed |
| US-20140284054-A1 | Methods for Consolidation Treatments in Subterranean Formations Using Silicon Compounds Derived from Furfuryl Alcohols | HALLIBURTON ENERGY SERVICES, INC. (US) | 2014-09-25 | — | — | US | disclosed |
| US-8779080-B2 | Silicon compounds derived from furfuryl alcohols and methods of preparation | GELEST TECHNOLOGIES, INC. (US) | 2014-07-15 | — | — | US | disclosed |
| US-20140046017-A1 | SILICON COMPOUNDS DERIVED FROM FURFURYL ALCOHOLS AND METHODS OF PREPARATION | GELEST TECHNOLOGIES, INC. (US) | 2014-02-13 | — | — | US | disclosed |
| US-20120226002-A1 | SILICON COMPOUNDS DERIVED FROM FURFURYL ALCOHOLS AND METHODS OF PREPARATION | GELEST TECHNOLOGIES, INC. (US) | 2012-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120226002-A1 | SILICON COMPOUNDS DERIVED FROM FURFURYL ALCOHOLS AND METHODS OF PREPARATION | SORD, ESPL1, FDFT1 | LMNA 2683/4885POLB 1957/4885ALDH1A1 356/4885 |
| US-20140046017-A1 | SILICON COMPOUNDS DERIVED FROM FURFURYL ALCOHOLS AND METHODS OF PREPARATION | SORD, ESPL1, FDFT1 | LMNA 2683/4885POLB 1957/4885ALDH1A1 356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.